Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...

Water fasting can lead to fast weight loss. But it also comes with real risks: inflammation, nutrient deficiencies, muscle ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Procalcitonin emerged as a strong diagnostic marker that may boost early SAP detection when combined with predictive models.

Researchers have found in a recent analysis reveals IL-17 inhibitors significantly increase the risk of Candida infections ...

The RABBIT registry is supported by a joint, unconditional grant from AbbVie, Alfasigma, Amgen, Biocon, Bristol Myers Squibb, Fresenius Kabi, Hexal, Eli Lilly, Pfizer, Samsung Bioepis, Sanofi Aventis, ...

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

A new study finds that hepatitis B heightens liver cancer risk by worsening inflammation and carcinogen impact, suggesting ...

Live webcasts and replays, when available, can be found under "News / Events" in the Investors section of the Avalo Therapeutics website at https://ir.avalotx.com. The archived webcast will be ...

Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.